Company · CIK 1557746
Aclaris Therapeutics, Inc.
| CIK | 1557746 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | PA |
| Listed | ACRS (Nasdaq) |
| First annual or quarterly report | 2015-11-18 |
Offerings
8 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298084 | 2026-08-06 | 2026-08-06 | 1 | |
| 333-285370 | 2025-02-27 | 2025-03-07 | 2 | |
| 333-283942 | 2024-12-19 | 2024-12-31 | 2 | |
| 333-256337 | 2021-05-20 | 2023-02-23 | 4 | |
| 333-237163 | 2020-03-13 | 2021-01-20 | 6 | |
| 333-214384 | 2016-11-02 | 2018-10-18 | 9 | |
| 333-212095 | 2016-06-17 | 2016-12-01 | 4 | |
| 333-206437 | 2015-08-17 | 2015-10-08 | 6 |
Filings
35| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-06 | S-3ASRShelf registered | 333-298084 | 0001104659-26-092113 |
| 2025-03-07 | EFFECTDeclared effective | 333-285370 | 9999999995-25-000615 |
| 2025-02-27 | S-3Shelf registered | 333-285370 | 0001104659-25-018310 |
| 2024-12-31 | EFFECTDeclared effective | 333-283942 | 9999999995-25-000016 |
| 2024-12-19 | S-3Shelf registered | 333-283942 | 0001104659-24-130186 |
| 2023-02-23 | 424B5Shelf takedown | 333-256337 | 0001104659-23-024747 |
| 2021-06-10 | 424B5Shelf takedown | 333-256337 | 0001104659-21-079447 |
| 2021-06-08 | 424B5Shelf takedown | 333-256337 | 0001104659-21-078253 |
| 2021-05-20 | S-3ASRShelf registered | 333-256337 | 0001104659-21-069961 |
| 2021-01-20 | 424B5Shelf takedown | 333-237163 | 0001104659-21-005890 |
| 2021-01-19 | 424B5Shelf takedown | 333-237163 | 0001104659-21-005302 |
| 2020-08-13 | 424B5Shelf takedown | 333-237163 | 0001104659-20-094778 |
| 2020-04-29 | EFFECTDeclared effective | 333-237163 | 9999999995-20-000907 |
| 2020-04-29 | 424B5Shelf takedown | 333-237163 | 0001104659-20-053341 |
| 2020-03-13 | S-3Shelf registered | 333-237163 | 0001104659-20-033140 |
| 2018-10-18 | 424B5Shelf takedown | 333-214384 | 0001047469-18-006765 |
| 2018-10-17 | 424B5Shelf takedown | 333-214384 | 0001047469-18-006747 |
| 2017-08-11 | 424B5Shelf takedown | 333-214384 | 0001047469-17-005193 |
| 2017-08-09 | 424B5Shelf takedown | 333-214384 | 0001047469-17-005132 |
| 2016-12-01 | EFFECTDeclared effective | 333-212095 | 9999999995-16-006350 |
| 2016-11-18 | 424B5Shelf takedown | 333-214384 | 0001047469-16-016808 |
| 2016-11-17 | 424B5Shelf takedown | 333-214384 | 0001047469-16-016766 |
| 2016-11-14 | EFFECTDeclared effective | 333-214384 | 9999999995-16-006236 |
| 2016-11-14 | 424B5Shelf takedown | 333-214384 | 0001104659-16-156904 |
| 2016-11-02 | S-3Shelf registered | 333-214384 | 0001104659-16-154162 |
| 2016-06-28 | EFFECTDeclared effective | 333-212095 | 9999999995-16-005019 |
| 2016-06-28 | 424B4Final prospectus | 333-212095 | 0001558370-16-006510 |
| 2016-06-17 | S-1Registration filed | 333-212095 | 0001558370-16-006418 |
| 2015-10-08 | 424B4Final prospectus | 333-206437 | 0001047469-15-007742 |
| 2015-10-06 | EFFECTDeclared effective | 333-206437 | 9999999995-15-002668 |
| 2015-10-01 | S-1/AAmendment | 333-206437 | 0001047469-15-007654 |
| 2015-09-25 | S-1/AAmendment | 333-206437 | 0001047469-15-007533 |
| 2015-09-04 | S-1/AAmendment | 333-206437 | 0001047469-15-007175 |
| 2015-08-17 | S-1Registration filed | 333-206437 | 0001047469-15-006870 |
| 2015-04-02 | DRSDraft made public | 377-00970 | 0000912057-15-000080 |